OVERLAND THERAPEUTICS Trademark

Trademark Overview


On Tuesday, September 12, 2023, a trademark application was filed for OVERLAND THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OVERLAND THERAPEUTICS trademark a serial number of 98176089. The federal status of this trademark filing is REGISTERED as of Tuesday, December 24, 2024. This trademark is owned by OVERLAND PHARMACEUTICALS (US) INC.,. The OVERLAND THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and pharmaceutical research services; pharmaceutical research and development
overland therapeutics

General Information


Serial Number98176089
Word MarkOVERLAND THERAPEUTICS
Filing DateTuesday, September 12, 2023
Status700 - REGISTERED
Status DateTuesday, December 24, 2024
Registration Number7628090
Registration DateTuesday, December 24, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements


NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesMedical and pharmaceutical research services; pharmaceutical research and development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 2, 2023
Primary Code042
First Use Anywhere DateFriday, September 20, 2024
First Use In Commerce DateFriday, September 20, 2024

Trademark Owner History


Party NameOVERLAND THERAPEUTICS (US) INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065

Party NameOVERLAND THERAPEUTICS (US) INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080

Party NameOVERLAND PHARMACEUTICALS (US) INC.,
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameOVERLAND PHARMACEUTICALS (US) INC.,
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Friday, September 15, 2023NEW APPLICATION ENTERED
Monday, October 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 7, 2024ASSIGNED TO EXAMINER
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, July 11, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 6, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 20, 2024USE AMENDMENT FILED
Friday, September 20, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, November 26, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 2, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, December 2, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 24, 2024REGISTERED-PRINCIPAL REGISTER
Saturday, December 28, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 24, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Saturday, December 28, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, December 28, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, December 28, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, December 28, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 5, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 5, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 5, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 5, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 5, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED